MCCA
AMGN icon

Mill Creek Capital Advisors’s Amgen AMGN Stock Holding History

Mill Creek Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
4,238
+125
+3% +$44.6K 0.03% 104
2025
Q4 		$1.35M Buy
4,113
+5
+0.1% +$1.59K 0.03% 112
2025
Q3 		$1.16M Buy
4,108
+364
+10% +$106K 0.02% 115
2025
Q2 		$1.05M Sell
3,744
-4
-0.1% -$1.13K 0.02% 116
2025
Q1 		$1.17M Sell
3,748
-141
-4% -$41.6K 0.03% 108
2024
Q4 		$1.01M Buy
3,889
+145
+4% +$43K 0.02% 118
2024
Q3 		$1.21M Sell
3,744
-371
-9% -$121K 0.03% 100
2024
Q2 		$1.29M Buy
4,115
+442
+12% +$130K 0.03% 102
2024
Q1 		$1.04M Sell
3,673
-66
-2% -$19.3K 0.03% 98
2023
Q4 		$1.08M Sell
3,739
-49
-1% -$13.4K 0.03% 98
2023
Q3 		$1.02M Sell
3,788
-261
-6% -$65.1K 0.03% 97
2023
Q2 		$899K Sell
4,049
-1,500
-27% -$348K 0.03% 107
2023
Q1 		$1.34M Buy
5,549
+1,800
+48% +$442K 0.05% 86
2022
Q4 		$985K Buy
+3,749
New +$1M 0.04% 95

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mill Creek Capital Advisors's AMGN Position: Q1 2026 in Review

Mill Creek Capital Advisors increased its Amgen (AMGN) stake by 3% in Q1 2026, buying an estimated $44.6K and bringing the position to 4,238 shares worth $1.49M. The position accounts for 0.03% of the portfolio, ranked #104.

Mill Creek Capital Advisors first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mill Creek Capital Advisors held 4,238 shares of Amgen worth $1.49M as of Q1 2026.
  • Mill Creek Capital Advisors bought 125 Amgen shares in Q1 2026, an estimated $44.6K.
  • Amgen made up 0.03% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #104 holding.
  • Mill Creek Capital Advisors first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.